Adverse effects of gender‐affirming hormonal therapy in transgender persons: Assessing reports in the French pharmacovigilance database

Limited data are available on adverse drug reactions (ADRs) of gender‐affirming hormone therapy (HT), mainly due to the lack of population‐based studies with adequate controls, thus making spontaneous reporting systems a valuable tool to detect potential side reactions. In this nationwide retrospect...

Descripción completa

Detalles Bibliográficos
Autores principales: Yelehe, Melissa, Klein, Marc, El Aridi, Layal, Maurier, Anaïs, Gillet, Pierre, Feigerlova, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796635/
https://www.ncbi.nlm.nih.gov/pubmed/35653182
http://dx.doi.org/10.1111/fcp.12806

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796635/
https://www.ncbi.nlm.nih.gov/pubmed/35653182
http://dx.doi.org/10.1111/fcp.12806

Ejemplares similares